A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen

Authors:

Abstract
Familial clustering of schizophrenia (SCZ), bipolar disorder (BPD), and major depressive disorder (MDD) was systematically reported (Aukes et al, Genet Med 2012, 14, 338‐341) and convergent evidence from genetics, symptomatology, and psychopharmacology imply that there are intrinsic connections between these three major psychiatric disorders, for example, any two or even three of these disorders could co‐exist in some families. A total of 60, 838 single‐nucleotide polymorphisms (SNPs) on chromosome 3 were genotyped by Affymetrix Genome‐Wide Human SNP array 6.0 on 119 SCZ, 253 BPD (type‐I), 177 MDD patients and 1,000 controls. Thepopulation ofShandong province was formed in 14 century and believed that it belongs to homogenous population. Associated SNPs were systematically revealed and outstanding susceptibility genes (CADPS, GRM7,KALRN, LSAMP, NLGN1, PRICKLE2, ROBO2) were identified. Unexpectedly, flanking genes for the associated SNPs distinctive for BPD and/or MDD were replicated in an enlarged cohort of 986 SCZ patients. The evidence from this chromosome 3 analysis supports the notion that both of bipolar and MDD might be subtypes of schizophrenia rather than independent disease entity. Also, a similar finding was detected on chromosome 5, 6, 7, and 8 (Chen et al. Am J Transl Res 2017;9 (5):2473–2491; Curr Mol Med 2016;16(9):840–854; Behav Brain Res 2015;293:241–251; Mol Neurobiol 2016. doi: 10.1007/s12035‐016‐0102‐1). Furthermore,PRICKLE2play an important role in the pathogenesis of three major psychoses in this population.
Funding Information
  • Natural Science Foundation of Shandong Province (ZR2013HM078, ZR 2010HQ051, Z2008C11, Z2004C10)
  • Ministry of Human Resources and Social Security (2009.416)

This publication has 134 references indexed in Scilit: